Exicure
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exicure and other ETFs, options, and stocks.About XCUR
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN.
CEOAndy Yoo
CEOAndy Yoo
Employees7
Employees7
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2011
Founded2011
Employees7
Employees7
XCUR Key Statistics
Market cap37.22M
Market cap37.22M
Price-Earnings ratio-4.03
Price-Earnings ratio-4.03
Dividend yield—
Dividend yield—
Average volume4.05M
Average volume4.05M
High today$6.26
High today$6.26
Low today$5.76
Low today$5.76
Open price$6.14
Open price$6.14
Volume69.75K
Volume69.75K
52 Week high$22.99
52 Week high$22.99
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
With a market cap of 37.22M, Exicure(XCUR) trades at $5.76. The stock has a price-to-earnings ratio of -4.03.
On 2025-12-17, Exicure(XCUR) stock traded between a low of $5.76 and a high of $6.26. Shares are currently priced at $5.76, which is 0.0% above the low and -8.0% below the high.
The Exicure(XCUR)'s current trading volume is 69.75K, compared to an average daily volume of 4.05M.
In the last year, Exicure(XCUR) shares hit a 52-week high of $22.99 and a 52-week low of $3.10.
In the last year, Exicure(XCUR) shares hit a 52-week high of $22.99 and a 52-week low of $3.10.
People also own
Based on the portfolios of people who own XCUR. This list is generated using Robinhood data, and it’s not a recommendation.